André Pèlegrin

5PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Te whai wāhi ākonga me ngā mahi whakaako o te Māori (Māori student engagement and teaching)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 13, 2025
Feasibility of Anti-CEA Dye Conjugate for Cancer-Specific Imaging in Gastric Cancer Cell Lines and Mouse Xenograft Models.

Kyoungyun Jeong, Annie Eunhee Koo, Jaeun Yoo

|Sep 28, 2021
Improving Biologics' Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures.

Christel Larbouret, Laurent Gros, André Pèlegrin

|Sep 09, 2020
Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using 111In-Labeled SGM-101.

Jan Marie de Gooyer, Fortuné M K Elekonawo, Desirée L Bos

|Jan 07, 2020
[Players from the program "Investments for the Future": MAbImprove MabEx].

Mélusine Larivière, André Pèlegrin, Pierre Martineau

|Jan 07, 2020
[Antibodies, tools of choice for fluorescence-guided surgery].

André Pèlegrin, Marian Gutowski, Françoise Cailler

Pageof 1

Frequent Collaborators

1 joint publications

Hervé Watier

1 joint publications

Fortuné M K Elekonawo

1 joint publications

Rachel S van der Post

1 joint publications

Françoise Cailler